ACH
ACCENDRA HEALTH INC/VA/
NYSE · Healthcare · Medical - Distribution · US
$0.46
−9.44%Price chart
Sep 3Sep 9Sep 14Sep 17Sep 22Sep 25Sep 30Oct 5
Key dataOct 5, 2026
Open$0.51
From 52W high−91.70%
Volume1.56M
Market cap$35.18M
P/E (TTM)—
P/S (TTM)0.0x
Div yield—
Key dataOct 5, 2026
Open
$0.51
From 52W high
−91.70%
Volume
1.56M
Market cap
$35.18M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
7.9x
P/E (TTM)
—
RSI (14)
16.0
MomentumView details →
1D Return
−9.44%
YTD Return
−81.80%
Similar companies
Latest newsMore news →
Accendra Health Inc. announced that Kenneth Gardner-Smith will succeed Edward A. Pesicka as President and Chief Executive Officer effective October 5, 2026, with Pesicka retiring from the CEO and director roles and transitioning to an advisory consulting arrangement.7d agoAccendra Health Inc. appointed Kenneth Gardner-Smith as President and Chief Executive Officer, succeeding retiring Edward A. Pesicka, and named Scott Lloyd as Chief Commercial Officer effective October 5, 2026.19d agoAccendra Health announced it will not implement an at-the-market equity issuance program due to recent market conditions, abandoning the plan to issue modest amounts of equity over time to reduce debt.50d ago